【新歌上架！！】

這是一首和 國立臺灣史前文化博物館 National Museum of Prehistory 及 蓋亞文化 出版的台灣史前奇幻冒險小說「風暴之子」擦出火花的歌曲－〈古老森林的後裔 Grandsons of Ancient Forest〉。
-
歌曲以風暴之子的故事情節為發想，用聲音和旋律來打造人們對於這個失落卻無比珍貴的臺灣古文明一卑南文化的情感連結。在三千多年前的部落裡，人們追隨著古老的信仰，彼此相依的在這塊土地上生活著，而這片土地，我們稱呼為「台灣」，你是否也曾聆聽過這片山林，山林裡長眠於此的人們，正在與我們訴說這片土地的美麗故事，而這一切從來就不該被遺忘。
-
＊ＮＥＷ ＳＯＮＧ ＲＥＬＥＡＳＥＤ＊
各大平台聆聽 Hear it at Digital Platform：https://snd.click/trt
ps. 部分國際平台因應年末假期會晚點曝光唷：Ｄ
Some platforms during the year-end holiday will postpone the release date 😀 More detailed song information is as follows!
-
特別謝謝帶我們了解許多卑南文化的 葉長庚、宜婷、芸甯，難忘那天驅車前往台東參觀卑南文化的遺址、由你們帶領我們翻閱文獻、近距離觀看這些出土文物，聆聽背景文化與故事。卑南文化做為台灣重要的史前文化之一，能有這些轉譯的發想與執行，每個環節都令人興奮，期待越來越多人以新的目光聆聽這些土地蘊藏的美麗故事。

－－－－
【歌曲介紹】

Vali，是風的古語，也曾是一名少年與一頭雲豹的名字。狂風暴雨中，一條獨木舟劇烈起伏，卻始終不曾沉沒。船上什麼都沒有，只有一個昏迷的小孩—瓦利。這個在風暴中存活的奇蹟男孩，在踏上海境的土地後，將以風為名，在異族部落裡蛻變重生，開啟屬於他的遠古冒險長征......。
-
歌曲內少年歌唱著一段部落長老們流傳的古老旋律，旋律裡唱述著：
Dee ie enssaa dnaaya（半月下的太陽之子）
Ii issee ento ui（靈魂永駐幻化成樹）
Kii inssee essaa libaya（聽，森林的細語唏囌）
io si kenna（唱述大地的美麗故事）
-
而歌曲開端則訴說：
Mriya dehita
iude taka emu
Ameyín sáiya
（所有神話的背後都源於一段真實故事）
-
主要演奏樂器為Lira de la estela de Luna，是由伊比利半島Luna（月亮）小鎮出土的一座石碑上圖案所復刻出的樂器，中文譯為月亮里拉琴（或稱塔特西里拉琴），該石碑目前存放於西班牙當地Zaragoza博物館，年代距今三千年左右，恰好與卑南文化時期有所重疊。歌曲中點綴著多種原始的傳統樂器，像是以羊趾甲製作而成的 Chajchas、早期以木頭製成的笛子 Quena、會發出下雨聲音的Palo de Lluvia 求雨棒、以種子製成的 Güiro de calabaza seca、跳舞專用的腳鈴 Pad Ghungroo、羊皮手鼓Frame Drum等等，期許用更開闊的聲響，編織出人們對於卑南文化的無限想像。

＊＊＊＊＊＊＊＊＊

【Information about Grandsons of Ancient Forest - Vali Original Soundtrack】

Vali is Taiwan’s first fantasy-adventure novel set in prehistoric times (more precisely, about 3,000 years ago). It is based on the Peinan culture.
-
• Plot: The word “vali” means “wind” in an ancient language of Taiwan, and it is also the name of the boy and clouded leopard in the story. During a fierce storm, a canoe is violently tossed about on the water, staying afloat in spite of the tempest. All that is in the canoe is an unconscious boy, whose survival is a miracle and who will later be named after the wind—“Vali.” He ends up living with a tribe that is not his own, transforming, experiencing rebirth, and embarking on a long adventure…
-
• About the song: The song, inspired by the plot of Vali, creates a musical and emotional link between listeners and a lost yet incomparably precious ancient civilization of Taiwan—the Peinan culture. Over 3,000 years ago, the inhabitants of a settlement on this island lived and depended on one another while following their religious beliefs. We call this island “Taiwan.” Have you ever listened carefully to its mountain forests and the people who sleep eternally in them? They are telling us the beautiful stories of Taiwan, stories that never should have been forgotten.
-
In the song, the boy sings an ancient melody passed down by the village elders, which goes:
Dee ie enssaa dnaaya (Children of the sun, beneath a half moon.)
Ii issee ento ui (Their spirits live eternally in the form of trees.)
Kii inssee essaa libaya (Hear the whispers of the forest,)
io si kenna (singing the beautiful stories of this land.)
-
The beginning of the song goes:
Mriya dehita
iude taka emu
Ameyín sáiya
(All myths are based on true stories.)
-
The main instrument is Lira de la estela de Luna(Lyre of Luna). It is the recreation of one of the oldest string instruments of the Iberian Peninsula. It was created based on an engraving representing a string instrument similar to an ancient Mediterranean lyre. This engraving is on an anthropomorphic funeral stele dating back three thousand years that was found in the town of Luna (Zaragoza) in 1975. The characteristics of the engraving are very similar to the style of the Tartessian period (10 to 6 B.C.).
Besides, this song is dotted with a variety of original traditional musical instruments, like Chajchas, Quena, Palo de Lluvia, Güiro de calabaza seca, Pad Ghungroo, Frame Drum, etc.

＊＊＊＊＊＊＊＊＊
小說《風暴之子》作者：奇幻作家 葛葉
封面繪師：Nofi
國立臺灣史前文化博物館授權

Yerko Fuenzalida Lorca

術後可調整度數及散光的人工水晶體 RxSight，正式被美國FDA通過，如果未來能在台灣上市，將是眼科醫師與患者的一大福音！

美國食品藥物管理局(FDA)昨(22)日批准了RxSight的光調節水晶體(light adjustable lens)和光傳遞設備(light delivery device, LDD)，這是第一個可以在白內障手術後，對人工水晶體(intraocular lens, IOL)進行小幅度調整的醫療器械系統，幫助患者不戴眼鏡也能擁有良好視力。

白內障通常是由於年紀增長，水晶體變硬或混濁，影響患者視力。也有些是由於外傷性、併發性(如青光眼)、代謝性(如糖尿病)等引起的白內障。

解決療法之一便是進行人工水晶體置換手術，然而許多患者會有些微屈光不正，需要使用眼鏡或隱形眼鏡矯正。

為了替患者解決人工水晶體不當聚焦的問題，RxSight 建構獨特材料IOL，在手術後17至21天，對LDD發出的紫外線進行反應。根據所需調整量，患者在1到2周內接受3或4次光照治療，每次約40-150秒。

白內障手術開始到光療結束，患者必須配戴特殊眼鏡防護紫外線，保護新水晶體免受紫外線照射影響。

FDA批准是基於針對此產品所做的試驗成果，該研究隨機性地在17個研究地點挑選600名患有散光的患者，比較了光調節水晶體與現有的單焦點水晶體。

使用光調節水晶體的患者接受輕度LDD治療，術後6個月的裸眼視力(uncorrected visual acuity, UCVA)達到20/20或更高，是接受單焦點水晶體患者的兩倍。與使用傳統IOL相比，患者平均遠距離裸眼視力在視力表上可多看清楚一行。

75%的患者散光也有所減少，91.8%使用光調節水晶體的患者也達到目標驗光球鏡度數(manifest refraction spherical equivalent)0.5D以內的結果，這與近期LASIK研究中所見屈光準確性相似。

FDA醫療器械暨輻射健康中心(Center for Devices and Radiological Health)眼科和耳鼻喉科部門主任Malvina Eydelman表示，到今天為止，白內障手術常見的屈光不正問題，都還得透過眼鏡矯正。不過這個系統為部分患者提供了一個新的選擇，使醫生在初次手術後，可進行多次，可在辦公室內操作的步驟，對植入的水晶體做些調整，提高不戴眼鏡的視力。

RxSight執行長Eric Weinberg指出，我們很高興全球首個手術後可調式IOL成功到達另一個里程碑，這對期待屈光人工水晶體技術再度突破的患者、外科醫生和驗光師來說，是一個相當令人振奮的機會。我們很感謝所有參與這項工作的人員，包括協助研究的臨床工作人員，以及準備審查監管報告的雙方(RxSight和FDA)工作人員。

感謝 David 提供中文翻譯。
資料來源：
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm586405.htm

The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens’ power after cataract surgery so that the patient will have better vision when not using glasses.
Cataracts are a common eye condition where the natural lens becomes clouded, impairing a patient’s vision. Following cataract surgery, during which the natural lens of the eye that has become cloudy is removed and replaced with an artificial lens (intraocular lens, or IOL), many patients have some minor residual refractive error requiring use of glasses or contact lenses. Refractive error, which is caused when the artificial lens does not focus properly, causes blurred vision.

“Until now, refractive errors that are common following cataract surgery could only be corrected with glasses, contact lenses or refractive surgery,” said Malvina Eydelman, M.D., director of the Division of Ophthalmic, and Ear, Nose and Throat at the FDA’s Center for Devices and Radiological Health. “This system provides a new option for certain patients that allows the physician to make small adjustments to the implanted lens during several in-office procedures after the initial surgery to improve visual acuity without glasses.”

The RxSight IOL is made of a unique material that reacts to UV light, which is delivered by the Light Delivery Device, 17-21 days after surgery. Patients receive three or four light treatments over a period of 1-2 weeks, each lasting about 40-150 seconds, depending upon the amount of adjustment needed. The patient must wear special eyeglasses for UV protection from the time of the cataract surgery to the end of the light treatments to protect the new lens from UV light in the environment.

A clinical study of 600 patients was conducted to evaluate the safety and effectiveness of the RxSight Light Adjustable Lens and Light Delivery Device. Six months after the procedure, patients on average saw an improvement of about one additional line down the vision chart, for distance vision without glasses, compared to a conventional IOL. Six months after surgery, 75 percent also had a reduction in astigmatism.

The device is intended for patients who have astigmatism (in the cornea) before surgery and who do not have macular diseases.

The device should not be used in patients taking systemic medication that may increase sensitivity to UV light such as tetracycline, doxycycline, psoralens, amiodarone, phenothiazines, chloroquine, hydrochlorothiazide, hypercin, ketoprofen, piroxicam, lomefloxacin and methoxsalen. Treatment in patients taking such medications may lead to irreversible eye damage. The device is also contraindicated in cases where patients have a history of ocular herpes simplex virus.

The FDA approved the Vision Light Adjustable Lens and the Light Delivery Device to RxSight Inc.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency is also responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.